Managing young people with Type 1 diabetes in a 'rave' new world: Metabolic complications of substance abuse in Type 1 diabetes

Diabetic Medicine

Volumn 26, Issue 4, 2009, Pages 328-333

  Lee, P ^a   Greenfield, J R ^a   Campbell, L V ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Cocaine; Ketamine; Ketoacidosis; Substance abuse; Type 1 Diabetes

Indexed keywords

3 HYDROXYBUTYRIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BICARBONATE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DESIGNER DRUG; DIAMORPHINE; DIPHENHYDRAMINE; GLUCOSE; INSULIN; KETAMINE; LYSERGIDE; METHADONE; METHAQUALONE; METHCATHINONE; OPIATE DERIVATIVE; RECREATIONAL DRUG; SOLVENT;

ADOLESCENCE; ADULTHOOD; DIABETIC KETOACIDOSIS; DIET THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; LIPOLYSIS; METABOLIC ACIDOSIS; METABOLIC DISORDER; MULTIPLE DRUG ABUSE; PATIENT CARE; PATIENT COMPLIANCE; POLYDIPSIA; PREVALENCE; REVIEW; SEIZURE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 64249147017     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02678.x     Document Type: Review

References (60)

1. Randall T. Ectasy-fuelled 'rave' parties become dances of death for English youths. J Am Med Assoc 1993 269 : 869 870.
2. Glasgow AM, Tynan D, Schwartz R, Hicks JM, Turek J, Driscol C et al. Alcohol and drug use in teenagers with diabetes mellitus. J Adolesc Health 1997 12 : 11 14.
3. Gold MA, Gladstein J. Substance use among adolescents with diabetes mellitus: preliminary findings. J Adolesc Health 1993 14 : 80 84.
4. Martínez-Aguayo A, Araneda JC, Fernandez D, Gleisner A, Perez V, Codner E. Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus. Pediatr Diabetes 2007 8 : 265 271.
5. Ng RS, Darko DA, Hillson RM. Street drug use among young patients with Type 1 diabetes in the UK. Diabet Med 2004 21 : 295 296.
6. Lee P, Greenfield JR, Campbell LV. "Mind the gap" when managing ketoacidosis in type 1 diabetes. Diabetes Care 2008 31 : e58.
7. Rattray M. Ecstasy: towards an understanding of the biochemical basis of the action of MDMA. Essays Biochem 1991 26 : 77.
8. Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of 'Club drugs'. Subst Use Misuse 2005 40 : 1189 1201.
9. Seymour HR, Gilman D, Quin JD. Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged exercise. Diabet Med 1996 13 : 908 909.
10. Giorgi FS, Lazzeri G, Natale G, Iudice A, Ruggieri S, Paparelli A et al. MDMA and seizures: a dangerous liaison? Ann N Y Acad Sci 2006 1074 : 357 364.
11. Rosenson J, Smollin C, Sporer KA, Blanc P, Olson KR. Patterns of ecstasy-associated hyponatremia in California. Ann Emerg Med 2007 49 : 164 171.
12. Kalantar-Zadeh K, Nguyen MK, Chang R, Kurtz I. Fatal hyponatremia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol 2006 2 : 283 288.
13. Ben-Abraham R, Szold O, Rudick V, Weinbroum AA. 'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur J Emerg Med 2003 10 : 309 313.
14. Brvar M, Kozelj G, Osredkar J, Mozina M, Gricar M, Bunc M. Polydipsia as another mechanism of hyponatremia after 'ecstasy' (3,4 methyldioxymethamphetamine) ingestion. Eur J Emerg Med 2004 11 : 302 304.
15. Kwon C, Zaritsky A, Dharnidharka VR. Transient proximal tubular renal injury following Ecstasy ingestion. Pediatr Nephrol 2003 18 : 820 822.
16. Lee P, Nicoll AJ, McDonough M, Colman PG. Substance abuse in young patients with type 1 diabetes: easily neglected in complex medical management. Intern Med J 2005 35 : 359 361.
17. Rome ES. It's a rave new world: rave culture and illicit drug use in the young. Cleve Clin J Med 2001 68 : 541 550.
18. Buchanan JF, Brown CR. 'Designer drugs'. A problem in clinical toxicology. Med Toxicol Adverse Drug Exp 1988 3 : 1.
19. Koesters SC, Rogers PD, Rajasingham CR. MDMA ('ecstasy') and other 'club drugs'. The new epidemic. Paediatr Clin North Am 2002 49 : 415.
20. Lee P, Campbell LV. Diabetic ketoacidosis: the usual villain or a scapegoat? A novel cause of severe metabolic acidosis in type 1 diabetes. Diabetes Care 2008 31 : e13.
21. Roervik S, Stovner J. Ketamine-induced acidosis, fever, and creatine-kinase rise. Lancet 1974 7 : 1384 1385.
22. Hibbs J, Perper J, Winek CL. An outbreak of designer drug-related deaths in Pennsylvania. J Am Med Assoc 1991 265 : 1011.
23. Byard RW, Riches KJ, Kostakis C, Felgate HE. Diabetic ketoacidosis - a possible complicating factor in deaths associated with drug overdose: two case reports. Med Sci Law 2006 46 : 81 84.
24. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001 39 : 32 41.
25. Abraham MR, Khardori R. Hyperglycemic hyperosmolar non-ketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser. Diabetes Care 1999 22 : 1380 1381.
26. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med 1997 157 : 669 675.
27. Warner EA, Greene GS, Buchsbaum MS, Cooper DS, Robinson BE. Diabetic ketoacidosis associated with cocaine use. Arch Intern Med 1998 158 : 1799 1802.
28. Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci 2007 9 : 413 430.
29. Permutt MA, Goodwin DW, Schwin R, Hill SY. The effect of marijuana on carbohydrate metabolism. Am J Psychiatry 1976 133 : 220 224.
30. Nyenwe EA, Loganathan RS, Blum S, Ezuteh DO, Erani DM, Wan JY et al. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract 2007 13 : 22 29.
31. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 2003 55 : 463 508.
32. Karch SB. Karch's Pathology of Drug Abuse. Boca Raton : CRC Press, 2002.
33. Frishman WH, Del Vecchio A, Sanal S, Ismail A. Cardiovascular manifestations of substance abuse. Part 2: Alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis 2003 5 : 253 569.
34. Yu Q, Montes S, Larson DF, Watson RR. Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice. Life Sci 2002 71 : 953 965.
35. He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol 1996 17 : 155 162.
36. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007 102 : 1204 1211.
37. Walters JM, Ward GM, Barton J, Arackal R, Boston RC, Best JD et al. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin dependent diabetes. Metabolism 1997 46 : 1448 1453.
38. Gerich JE, Lorenzi M, Karam JH. Studies on the mechanism of epinephrine-induced hyperglycemia in man: evidence for participation of pancreatic glucagon secretion. Diabetes 1976 25 : 65 71.
39. Sherline P, Lynch A, Glinsmann WH. Cyclic AMP and adrenergic receptor control of rat liver glycogen metabolism. Endocrinology 1972 91 : 680 690.
40. Exton JH, Park CR. Control of gluconeogenesis in liver. I I: Effects of glucagon, catecholamines, and adenosine-3′, 5′-monophosphate on gluconeogenesis in the perfused rat liver. J Biol Chem 1968 243 : 4189 4196.
41. Brown ET, Umino Y, Loi T, Solessio E, Barlow R. Anesthesia can cause sustained hyperglycemia in C57/BL6J mice. Vis Neurosci 2005 22 : 615 618.
42. Saha JK, Xia J, Grondin JM, Engle SK, Jakubowski JA. Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp Biol Med (Maywood) 2005 230 : 777 784.
43. Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 1984 7 : 92 98.
44. Passariello N, Giugliano D, Ceriello A, Chiariello A, Sgambato S, D'Onofrio F. Impaired insulin response to glucose but not to arginine in heroin addicts. J Endocrinol Invest 1986 9 : 353 357.
45. Rott D, Langleben DD, Elman I. Cocaine decreases plasma insulin concentrations in non-diabetic subjects: a randomized double-blind study. Diabet Med 2008 25 : 510 511.
46. Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, Segura J et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999 290 : 136 145.
47. Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 2002 162 : 396 405.
48. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes Res 1997 5 : 341 347.
49. Collins S, Surwit RS. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001 56 : 309 328.
50. Fox IH, Halperin ML, Goldstein MB, Marliss EB. Renal excretion of uric acid during prolonged fasting. Metabolism 1976 25 : 551 559.
51. Brown JH, Hadden DR, Hadden DS. Solvent abuse, toluene acidosis and diabetic ketoacidosis. Arch Emerg Med 1991 8 : 65 67.
52. Dymot JA, McKay GA. Type 1 (distal) renal tubular acidosis in a patient with Type 1 diabetes mellitus - not all cases of metabolic acidosis in Type 1 diabetes mellitus are due to diabetic ketoacidosis. Diabet Med 2008 25 : 114 115.
53. Busse F, Omidi L, Leichtle A, Windgassen M, Kluge E, Stumvoll M. Lead poisoning due to adulterated marijuana. N Engl J Med 2008 358 : 1641 1642.
54. Gonzalez JJ, Werk EE Jr., Thrasher K, Behar R, Loadholt CB. Renin aldosterone system and potassium levels in chronic lead intoxication. South Med J 1979 72 : 433 436.
55. Ashouri OS. Hyperkalemic distal renal tubular acidosis and selective aldosterone deficiency. Combination in a patient with lead nephropathy. Arch Intern Med 1985 145 : 1306 1307.
56. Lua AC, Lin HR, Tseng YT, Hu AR, Yeh PC. Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. Forensic Sci Int 2003 136 : 47 51.
57. Schreiber M, Steele A, Goguen J, Levin A, Halperin M. Can a severe degree of ketoacidosis develop overnight J Am Soc Nephrol 1996 7 : 192 197.
58. Bryden KS, Dunger DB, Mayou RA, Peveler RC, Neil HA. Poor prognosis of young adults with type 1 diabetes: a longitudinal study. Diabetes Care 2003 26 : 1052 1057.
59. Bryden KS, Peveler RC, Stein A, Neil A, Mayou RA, Dunger DB. Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care 2001 24 : 1536 1540.
60. Laing SP, Jones ME, Swerdlow AJ, Burden AC, Gatling W. Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes. Diabetes Care 2005 28 : 1618 1623.